Timeline set for negotiating Medicare drug prices
CMS Administrator Chiquita Brooks-LaSure announced that the first 10 Medicare Part D drugs selected for price negotiations will be made public by Sept. 1.
Stay updated with breaking news from Peter Loftus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CMS Administrator Chiquita Brooks-LaSure announced that the first 10 Medicare Part D drugs selected for price negotiations will be made public by Sept. 1.
Leqembi’s manufacturers estimate the drug will be available by Jan. 23 and have priced the biweekly infusion at $26,500 annually.
Blood tests designed to detect cancer at an early stage is welcome news and a signal of hope for millions of people suffering from cancer.
And Donald Trump's legal team is fighting an under-the-radar court battle.
As restaurants continue to try to stay alive post-pandemic, managers in D.C. say the cost of food isn't the only thing hurting their businesses.